Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Kessler

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 15, 2000
Total system performance assessment for waste disposal using a logic tree approachJ H Kessler, R K McGuire
Leukemia|July 6, 2007
Identification of T-cell epitopes for cancer immunotherapyJ H Kessler, C J M Melief
Journal of Environmental Radioactivity|June 21, 2005
"Reference Biospheres" for solid radioactive waste disposal: the BIOMASS methodologyI G Crossland, P Pinedo, J H Kessler, et al.
Cell Death & Disease|April 12, 2014
Betulinic acid-induced mitochondria-dependent cell death is counterbalanced by an autophagic salvage responseL Potze, F B Mullauer, S Colak, et al.
Blood|November 1, 1996
Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptideG J Bosch, A M Joosten, J H Kessler, et al.
Leukemia & Lymphoma|May 16, 2000
BCR-ABL directed immunotherapy: a virtual reality?O C Leeksma, J H Kessler, I J Huijbers, et al.
British Journal of Haematology|January 14, 1999
BCR-ABL oncoprotein is expressed by platelets from CML patients and associated with a special pattern of CrkL phosphorylationG J ten Bosch, J H Kessler, J Blom, et al.
Blood|July 27, 1999
A BCR-ABL oncoprotein p210b2a2 fusion region sequence is recognized by HLA-DR2a restricted cytotoxic T lymphocytes and presented by HLA-DR matched cells transfected with an Ii(b2a2) constructG J ten Bosch, J H Kessler, A M Joosten, et al.
Annals of Emergency Medicine|April 1, 1984
Treatment of prehospital refractory ventricular fibrillation with bretylium tosylateJ M Stang, S E Washington, S A Barnes, et al.
Leukemia|August 26, 2006
BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopesJ H Kessler, S A Bres-Vloemans, P A van Veelen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 15, 2000
Total system performance assessment for waste disposal using a logic tree approachJ H Kessler, R K McGuire
Leukemia|July 6, 2007
Identification of T-cell epitopes for cancer immunotherapyJ H Kessler, C J M Melief
Journal of Environmental Radioactivity|June 21, 2005
"Reference Biospheres" for solid radioactive waste disposal: the BIOMASS methodologyI G Crossland, P Pinedo, J H Kessler, et al.
Cell Death & Disease|April 12, 2014
Betulinic acid-induced mitochondria-dependent cell death is counterbalanced by an autophagic salvage responseL Potze, F B Mullauer, S Colak, et al.
Blood|November 1, 1996
Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptideG J Bosch, A M Joosten, J H Kessler, et al.
Leukemia & Lymphoma|May 16, 2000
BCR-ABL directed immunotherapy: a virtual reality?O C Leeksma, J H Kessler, I J Huijbers, et al.
British Journal of Haematology|January 14, 1999
BCR-ABL oncoprotein is expressed by platelets from CML patients and associated with a special pattern of CrkL phosphorylationG J ten Bosch, J H Kessler, J Blom, et al.
Blood|July 27, 1999
A BCR-ABL oncoprotein p210b2a2 fusion region sequence is recognized by HLA-DR2a restricted cytotoxic T lymphocytes and presented by HLA-DR matched cells transfected with an Ii(b2a2) constructG J ten Bosch, J H Kessler, A M Joosten, et al.
Annals of Emergency Medicine|April 1, 1984
Treatment of prehospital refractory ventricular fibrillation with bretylium tosylateJ M Stang, S E Washington, S A Barnes, et al.
Leukemia|August 26, 2006
BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopesJ H Kessler, S A Bres-Vloemans, P A van Veelen, et al.
Pageof 2